Dr. Mark A. Klein
Claim this profileMinneapolis VA Medical Center
Studies Cancer
Studies Lung Cancer
14 reported clinical trials
24 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage III
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Mark A. Klein is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Mark A. Klein
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Mark A. Klein has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Venetoclax
- Obinutuzumab
- Pemetrexed
Breakdown of trials Mark A. Klein has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark A. Klein specialize in?
Mark A. Klein focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Mark A. Klein currently recruiting for clinical trials?
Yes, Mark A. Klein is currently recruiting for 5 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Mark A. Klein has studied deeply?
Yes, Mark A. Klein has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Mark A. Klein?
Apply for one of the trials that Mark A. Klein is conducting.
What is the office address of Mark A. Klein?
The office of Mark A. Klein is located at: Minneapolis VA Medical Center, Minneapolis, Minnesota 55417 United States. This is the address for their practice at the Minneapolis VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.